
Cancer. The body changes. The terrain changes. The rules change. Making sense of biological shifts in remission through lived experience and structured reasoning.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 27 | Founded | 4 months ago | Last Issue | 9 days ago |
| Active | |||||

Since being diagnosed with cancer, I have made integrative cancer support part of my strategy. It has been quite a road, with ups and downs, and a steep learning curve. On several occasions, advocating for my own care has made a real differ...
Thymosin alpha-1 has been approved in more than 35 countries, tested in thousands of cancer patients and used in clinical trials spanning hepatitis, melanoma, lung cancer and sepsis.
There is a peptide that has been approved in more than 3...
If you’ve been diagnosed with cancer and you’re taking a daily multivitamin, there’s a near-certain ingredient inside it that your oncologist has almost certainly never mentioned: folic acid. It’s B9. The nutrient behind pregnancy health ca...
There is a weed that has been growing wild for centuries. People have been using it as medicine for over 2,000 years. It ended up in a randomized controlled trial at a major cancer center. And it helped children on chemotherapy keep their l...
After treatment ended, I got the result every patient wants: pCR, or pathologic complete response. No tumor cells in the removed tissue. Clear margins. No positive lymph nodes. NED — no evidence of disease.
Everyone congratulated me.
But...
Subscribers, engagement, traffic and sponsorship for The Cancer Strategist.
| Subscribers | Engagement | 79 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Integrative cancer strategies: what works, what doesn’t, and what can backfire. MSc, analyst — I look at what the research says and what life actually teaches. From diagnosis to remission, I’m tracking this in real time.
You can find recent issues that have been published by The Cancer Strategist on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The Cancer Strategist, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Cancer Strategist as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Cancer Strategist using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The Cancer Strategist. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.